This figure corresponds to the first full year of applying the single-dose regimen, a strategy aimed at improving vaccination coverage and simplifying the vaccination schedule. The distribution by provinces shows uniform implementation: 55,249 doses in Valencia, 37,348 in Alicante, and 12,529 in Castellón.

The Valencian Community adopted the single-dose regimen in 2024, a decision supported by international organizations such as the World Health Organization and the European Centre for Disease Prevention and Control. During 2025, this strategy has been consolidated, with a predominance of 75,788 first doses administered, compared to 20,739 second doses and 8,608 additional doses.

The HPV vaccine is included in the regional vaccination calendar and is administered at 12 years of age, to both girls and boys, to ensure immunization before exposure to the virus. Furthermore, the new 2026 vaccination calendar reinforces this strategy by extending vaccination up to 21 years of age, with the aim of including males born between 2005 and 2010 who had not been previously vaccinated.

This vaccine is a fundamental tool in the primary prevention of cancer. Scientific evidence demonstrates its effectiveness against cervical cancer and its ability to significantly reduce the risk of other tumors such as those of the anus, penis, vulva, and oropharynx, as well as preventing the appearance of genital warts.

HPV is a very common virus transmitted through intimate contact. Although many infections resolve spontaneously, some can persist and evolve into precancerous lesions and cancer years later. Early vaccination provides solid and lasting protection, with a direct impact on public health. This initiative, along with population screening programs, is part of a comprehensive strategy to eliminate cervical cancer as a public health problem, in line with the World Health Organization's objective.